The story of Sildenafil presents a challenging picture for shareholders. While the initial release generated significant gains, the expiration of its intellectual property protection opened the door to cheaper alternatives, dramatically eroding sales. This presents a specific challenge for pharmaceutical companies banking on related blockbuster pro

The history of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, producing billions in sales , its intellectual property lapse created click here a wave of knock-off medications, significantly eroding its position . While some pharmaceutical companies may try to capitalize on re